| Trial ID: | L4630 |
| Source ID: | NCT06071208
|
| Associated Drug: |
Gliflozin
|
| Title: |
Prevent Diabetic Kidney Disease Among Egyptians
|
| Acronym: |
|
| Status: |
NOT_YET_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Without Complication
|
| Interventions: |
DRUG: Gliflozin
|
| Outcome Measures: |
Primary: prevention of diabetic complications, glomerular filtration rate will be measured at the beginning of the study and at the end, 5 years |
|
| Sponsor/Collaborators: |
Sponsor: Fayoum University | Collaborators: Cairo University|NewGiza University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
10000
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2023-10-14
|
| Completion Date: |
2028-12-14
|
| Results First Posted: |
|
| Last Update Posted: |
2023-10-10
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT06071208
|
